Addressing demand for recombinant biopharmaceuticals in the COVID-19 era

Addressing demand for recombinant biopharmaceuticals in the COVID-19 era

Bibliographic Details
Main Authors:	Balamurugan Shanmugaraj, Waranyoo Phoolcharoen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Asian Pacific Journal of Tropical Medicine
Online Access:	http://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=2;spage=49;epage=51;aulast=Shanmugaraj

Similar Items

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
by: Balamurugan Shanmugaraj, et al.
Published: (2020-07-01)

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
by: Balamurugan Shanmugaraj, et al.
Published: (2020-02-01)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
by: Wanuttha Boonyayothin, et al.
Published: (2021-06-01)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
by: Balamurugan Shanmugaraj, et al.
Published: (2020-11-01)

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
by: Balamurugan Shanmugaraj, et al.
Published: (2021-08-01)

Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
by: Balamurugan Shanmugaraj, et al.
Published: (2021-07-01)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
by: Konlavat Siriwattananon, et al.
Published: (2021-01-01)

Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana
by: Oranicha Hanittinan, et al.
Published: (2020-12-01)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
by: Kaewta Rattanapisit, et al.
Published: (2021-01-01)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
by: Kaewta Rattanapisit, et al.
Published: (2021-01-01)

Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species
by: Ashwini Malla, et al.
Published: (2021-04-01)

Development of an integrated platform for the production of recombinant biopharmaceuticals
by: Segarra, Camille
Published: (2013)

Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis
by: Kaewta Rattanapisit, et al.
Published: (2019-03-01)

Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity
by: Christine Joy I. Bulaon, et al.
Published: (2020-09-01)

Addressing the caste system in U.S. healthcare in the era of COVID-19
by: Karthik Sivashanker, et al.
Published: (2020-10-01)

Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae
by: Lorenzo Barolo, et al.
Published: (2020-03-01)

Analysis and exploitation of GPI anchors in the expression of recombinant protein biopharmaceuticals
by: Riley, Aidan
Published: (2012)

Production of spike and nucleocapsid recombinant proteins of porcine epidemic diarrhea virus for antibody detection by ELISA
by: Anchalee Srijangwad, et al.
Published: (2016-02-01)

Ethical research in the COVID-19 era demands care, solidarity and trustworthiness
by: Kate Chatfield, et al.
Published: (2020-07-01)

Recombinant human dentin matrix protein 1 (DMP1) induces the osteogenic differentiation of human periodontal ligament cells
by: Aktsar Roskiana Ahmad, et al.
Published: (2019-09-01)

Effect of Population Lockdown on Pediatric Emergency Room Demands in the Era of COVID-19
by: Francesco Valitutti, et al.
Published: (2020-09-01)

Prescribing Phones to Address Health Equity Needs in the COVID-19 Era: The PHONE-CONNECT Program
by: Kazevman, Gill, et al.
Published: (2021-04-01)

Addressing the post‐COVID era through engineering biology
by: Jennifer Bell, et al.
Published: (2021-06-01)

Alliances of leading biopharmaceutical companies as a strategic axis for the development of anti-COVID-19 vaccines
by: José Miguel Rodríguez Perón, et al.
Published: (2021-04-01)

A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
by: B. Owczarek, et al.
Published: (2019-01-01)

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
by: Konlavat Siriwattananon, et al.
Published: (2021-07-01)

Biopharmaceutics of phenylpropanolamine
by: Dowse, Roslind
Published: (1984)

The Post-COVID-19 Era: Interdisciplinary Demands of Contagion Surveillance Mass Spectrometry for Future Pandemics
by: Chaitanya Giri, et al.
Published: (2021-07-01)

Loneliness in the Era of COVID-19
by: Eric D. Miller
Published: (2020-09-01)

Misdiagnosis in the COVID-19 Era
by: Rayan Yousefzai, MD, et al.
Published: (2020-08-01)

Cyberbiosecurity for Biopharmaceutical Products
by: Jennifer L. Mantle, et al.
Published: (2019-05-01)

Globalization of biopharmaceutical manufacturing
by: Pande, Rachna
Published: (2012)

Supramolecular PEGylation of biopharmaceuticals
by: Vinciguerra, Brittany, et al.
Published: (2017)

Biopharmaceutical studies of Tenoxicam
by: Yu,Du-Wun, et al.
Published: (1996)

Biopharmaceutical studies of Tenoxicam
by: Yu, Du-Wen, et al.
Published: (1996)

Issues of Patent in Biopharmaceuticals
by: Hung-Li Chen, et al.
Published: (2011)

Biopharmaceutical Studies of Licorice
by: Hui Ching, et al.
Published: (2001)

Pharmacokinetics and Biopharmaceutics of Chlorthalidone
by: Parr, G. D.
Published: (1979)

Biopharmaceutical studies on methaqualone
by: Williams, Margaret E.
Published: (1975)

VIRAL BIOSAFETY OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01)